Literature DB >> 29469956

IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression.

Hussein F Aqbi1,2, Matthew Wallace1, Samay Sappal1, Kyle K Payne3, Masoud H Manjili1,2.   

Abstract

Tumor immunoediting consisting of three phases of elimination, equilibrium or dormancy, and escape has been supported by preclinical and clinical data. A comprehensive understanding of the molecular mechanisms by which antitumor immune responses regulate these three phases are important for developing highly tailored immunotherapeutics that can control cancer. To this end, IFN-γ produced by Th1 cells, cytotoxic T cells, NK cells, and NKT cells is a pleiotropic cytokine that is involved in all three phases of tumor immunoediting, as well as during inflammation-mediated tumorigenesis processes. This essay presents a review of literature and suggests that overcoming tumor escape is feasible by driving tumor cells into a state of quiescent but not indolent dormancy in order for IFN-γ-producing tumor-specific T cells to prevent tumor relapse. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  IFN-γ; immunotherapy; tumor dormancy; tumor immunoediting

Year:  2018        PMID: 29469956      PMCID: PMC6157004          DOI: 10.1002/JLB.5MIR0917-351R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  50 in total

Review 1.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.

Authors:  Nicholas McGranahan; Charles Swanton
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

2.  HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses.

Authors:  Maciej Kmieciak; Keith L Knutson; Catherine I Dumur; Masoud H Manjili
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

3.  HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.

Authors:  Anupama Sharma; Ursula Koldovsky; Shuwen Xu; Rosemarie Mick; Robert Roses; Elizabeth Fitzpatrick; Susan Weinstein; Harvey Nisenbaum; Bruce L Levine; Kevin Fox; Paul Zhang; Gary Koski; Brian J Czerniecki
Journal:  Cancer       Date:  2012-01-17       Impact factor: 6.860

Review 4.  Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

Authors:  Kenneth Cusi
Journal:  Gastroenterology       Date:  2012-02-08       Impact factor: 22.682

5.  Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals.

Authors:  Marcin Kortylewski; Waraporn Komyod; Maria-Elisabeth Kauffmann; Anja Bosserhoff; Peter C Heinrich; Iris Behrmann
Journal:  J Invest Dermatol       Date:  2004-02       Impact factor: 8.551

6.  IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.

Authors:  X Xu; X Y Fu; J Plate; A S Chong
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

7.  Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease.

Authors:  Chia-Chu Chang; Chia-Lin Wu; Wei-Wen Su; Kai-Lun Shih; Der-Cherng Tarng; Chen-Te Chou; Ting-Yu Chen; Chew-Teng Kor; Hung-Ming Wu
Journal:  Sci Rep       Date:  2015-05-11       Impact factor: 4.379

8.  Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression.

Authors:  Roberto Bellucci; Allison Martin; Davide Bommarito; Kathy Wang; Steen H Hansen; Gordon J Freeman; Jerome Ritz
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

9.  IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.

Authors:  Kazuyoshi Takeda; Masafumi Nakayama; Yoshihiro Hayakawa; Yuko Kojima; Hiroaki Ikeda; Naoko Imai; Kouetsu Ogasawara; Ko Okumura; David M Thomas; Mark J Smyth
Journal:  Nat Commun       Date:  2017-02-24       Impact factor: 14.919

10.  High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer.

Authors:  Piotr Tymoszuk; Pornpimol Charoentong; Hubert Hackl; Rita Spilka; Elisabeth Müller-Holzner; Zlatko Trajanoski; Peter Obrist; Françoise Revillion; Jean-Philippe Peyrat; Heidi Fiegl; Wolfgang Doppler
Journal:  BMC Cancer       Date:  2014-04-12       Impact factor: 4.430

View more
  28 in total

1.  Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

Authors:  Ian MacFawn; Hannah Wilson; Luke A Selth; Ian Leighton; Ilya Serebriiskii; R Christopher Bleackley; Osama Elzamzamy; Joshua Farris; Phillip M Pifer; Jennifer Richer; Steven M Frisch
Journal:  Mol Immunol       Date:  2018-11-30       Impact factor: 4.407

2.  [Interleukin-17 promotes mouse hepatoma cell proliferation by antagonizing interferon-γ].

Authors:  Jie Li; Kun Yan; Yi Yang; Hua Li; Zhidong Wang; Xin Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

3.  Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30- Tumors.

Authors:  Andreas A Hombach; Gunter Rappl; Hinrich Abken
Journal:  Mol Ther       Date:  2019-06-19       Impact factor: 11.454

4.  IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration.

Authors:  Sveta Padmanabhan; Bijaya Gaire; Yue Zou; Mohammad M Uddin; Daniel DeLeon; Ivana Vancurova
Journal:  Int J Biochem Cell Biol       Date:  2021-10-06       Impact factor: 5.085

5.  The Interferon-Gamma Paradox in Cancer.

Authors:  M Raza Zaidi
Journal:  J Interferon Cytokine Res       Date:  2018-11-09       Impact factor: 2.607

Review 6.  Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse.

Authors:  Saeed H Manjili; Madison Isbell; Negar Ghochaghi; Tyler Perkinson; Masoud H Manjili
Journal:  Semin Cancer Biol       Date:  2021-03-27       Impact factor: 15.707

7.  Endometrial Cancer Suppresses CD8+ T Cell-Mediated Cytotoxicity in Postmenopausal Women.

Authors:  Mickey V Patel; Zheng Shen; Marta Rodriguez-Garcia; Edward J Usherwood; Laura J Tafe; Charles R Wira
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 8.  Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells.

Authors:  Scott Sauer; Damon R Reed; Michael Ihnat; Robert E Hurst; David Warshawsky; Dalit Barkan
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

Review 9.  Cellular stress responses and metabolic reprogramming in cancer progression and dormancy.

Authors:  Kyle K Payne
Journal:  Semin Cancer Biol       Date:  2021-06-04       Impact factor: 15.707

10.  Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells.

Authors:  Dina Morein; Linor Rubinstein-Achiasaf; Hadar Brayer; Orly Dorot; Edward Pichinuk; Hagar Ben-Yaakov; Tsipi Meshel; Metsada Pasmanik-Chor; Adit Ben-Baruch
Journal:  Cells       Date:  2021-05-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.